A cluster of differentiation 44 (CD44), a transmembrane molecule, senses microenvironmental tumor changes by linking to ECM constituents, such as hyaluronic acid (HA), and promotes extracellular signals to control tumor development. This evidence concerns the gene CD44 and neoplasm.